JPS6064909A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPS6064909A
JPS6064909A JP58173398A JP17339883A JPS6064909A JP S6064909 A JPS6064909 A JP S6064909A JP 58173398 A JP58173398 A JP 58173398A JP 17339883 A JP17339883 A JP 17339883A JP S6064909 A JPS6064909 A JP S6064909A
Authority
JP
Japan
Prior art keywords
cosmetic
wound
extract
skin
spleen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58173398A
Other languages
Japanese (ja)
Other versions
JPH0412243B2 (en
Inventor
Kenji Tsutsumi
堤 謙治
Takashi Eda
枝 尚
Tokiya Yokoi
時也 横井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP58173398A priority Critical patent/JPS6064909A/en
Publication of JPS6064909A publication Critical patent/JPS6064909A/en
Publication of JPH0412243B2 publication Critical patent/JPH0412243B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE:To provide a cosmetic having excellent effect to cure the wound, and containing an aqueous extract of the liver or spleen of mammals and a skin extract. CONSTITUTION:The objective cosmetic having synergistically improved wound- curing effect can be produced by compounding (A) an aqueous extract of the liver or spleen of mammals such as cattle, pig, etc. and (B) a skin extract such as mucopolysaccharide (e.g. hyaluronic acid, dermatan sulfate, chondroitinsulfuric acid, or their salts), collagen, elastin, etc. to a skin cosmetic such as beauty lotion, cream, milky lotion, pack, etc. The amount of the components A and B are generally 0.001-2wt% (in terms of dried residue) and 0.005-2wt% (in terms of solid component), based on the whole cosmetic composition. Since the excellent wound-curing effect can be maintained even by adding a component having suppressing effect against the curing of wound to the above cosmetic, the components used generally in cosmetics can be added to the above cosmetic in addition to the above components, according to the use.

Description

【発明の詳細な説明】 本発明はホ乳類の肝臓又は牌臓からの水抽出物とムコ多
糖やコラーゲン、エラスチン等の皮+i1エキスとを含
有してなる創傷治癒効果に優れた化粧料に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a cosmetic product containing an aqueous extract from the liver or spleen of a mammal and a skin + i1 extract of mucopolysaccharide, collagen, elastin, etc., and which has an excellent wound healing effect. .

従来、成心美白効果や創傷治癒効果を目的に、ホ乳類の
肝臓、牌臓あるいは胎盤等の器官からの抽出物を化粧料
に配合することは一般的に行われていた。
BACKGROUND ART Conventionally, extracts from organs such as the liver, spleen, or placenta of mammals have been commonly incorporated into cosmetics for the purpose of skin whitening and wound healing effects.

一方、上記皮膚エキスは創傷治癒効果を有することが知
られている。
On the other hand, the above skin extract is known to have a wound healing effect.

しかしながら、上記の抽出物及び皮膚エキスの創傷治癒
効果は単独ではいずれも未だ不満足なものであった。
However, the wound healing effects of the above extracts and skin extracts were still unsatisfactory when used alone.

本発明者等は上記の事情に鑑み鋭意研究した結果、上記
抽出物の中でもホ乳類の肝臓又は牌臓からの水抽出物に
、皮膚エキスを組み合せて用いたならば相剰的に効果が
増大し、もって従来の創傷泊倫剤には見られなかった優
れた創傷治癒効果を発揮することを見い出し、本発明を
完成するに至った。
In view of the above circumstances, the present inventors conducted intensive research and found that among the above extracts, if water extracts from mammalian livers or spleens are used in combination with skin extracts, they will have a complementary effect. The present inventors have discovered that the present invention has been completed based on the discovery that the present invention has an excellent wound healing effect that has not been seen in conventional wound healing agents.

すなわち、本発明は、ホ乳類の肝臓又は牌臓からの水抽
出物と皮1腎エキスとを含有することを特徴とする化粧
料である。
That is, the present invention is a cosmetic material containing an aqueous extract from the liver or spleen of a mammal and a skin and kidney extract.

以下・本発明の構成について詳述する。Below, the configuration of the present invention will be explained in detail.

に従って行えば良いが、−例を挙げると次の通りである
The following is an example.

新鮮な牛の冷凍牌臓を粉砕し、60’(:以上の熱水で
1時間以上かけて抽出し、さらに凹℃以上で10分間以
上加熱した後、口過し濃縮する。濃縮物にエチルアルコ
ールを加えて口過し脱タンパクtzWJ溶化する。この
ようにして得られた水抽出物中Gこ含まれている水溶林
の低分子有効分の分子量Gま約100〜10,000の
範囲内にある。
Fresh frozen beef spleen is crushed, extracted with hot water over 60°C for over 1 hour, further heated at over 10°C for over 10 minutes, passed through the mouth and concentrated. Add alcohol and pass through the mouth to dissolve the deproteinized protein.The molecular weight of the low-molecular effective components of the aqueous forest contained in the aqueous extract thus obtained is within the range of about 100 to 10,000. It is in.

上記水抽出物は熱に対して安定であり、格段の処理を加
えることなくそのままでも化粧水、り1ノーム、乳液等
の化粧料に配合することができる。
The aqueous extract is stable against heat and can be incorporated into cosmetics such as lotion, Ri1nome, and milky lotion as it is without any special treatment.

一般に配合量は乾燥残渣で化粧量全量中の0.001〜
2重量%である。
Generally, the amount of dry residue is 0.001 to 0.001 of the total amount of makeup.
It is 2% by weight.

本発明に用いる皮膚エキスはムコ多糖、例えばヒアルロ
ン酸、デルマタン硫酸、コンドロイチン硫酸及びそれら
の塩類及びコラーゲン、エラスチン等であり、これらの
うちの1種又は2種以上が任意に選ばれて用いられる。
The skin extract used in the present invention includes mucopolysaccharides such as hyaluronic acid, dermatan sulfate, chondroitin sulfate and salts thereof, collagen, elastin, etc., and one or more of these may be arbitrarily selected and used.

配合量は一般的に0005〜2重量%(固形分)である
The blending amount is generally 0.005 to 2% by weight (solid content).

(以下余白) 本発明の化粧料は、一般的に化粧料に配合した場合創傷
治癒に対して抑制的に作用するような成分を配合しても
、優れた創傷治癒効果を有する。
(Hereinafter, blank spaces) The cosmetic of the present invention has an excellent wound healing effect even if it contains ingredients that generally act to suppress wound healing when added to a cosmetic.

従って、必須構成成分の他に一般的に化粧料に配合され
るその他の成分を目的製品に応じて任意に配合し得る。
Therefore, in addition to the essential constituents, other ingredients commonly incorporated into cosmetics may be optionally blended depending on the desired product.

例えば、界面活性剤、水、油分、アルコール類、防腐剤
、色剤、香料等である。不発に創傷治癒試験例を具体的
に説明する。
For example, surfactants, water, oils, alcohols, preservatives, colorants, fragrances, etc. An example of an unexploded wound healing test will be specifically explained.

〔試験例1〕 生後6週齢のウィスター系う、) (SPF)を5匹1
群とし、毛刈の後試験に供した。
[Test Example 1] 5 6-week-old Wistar (SPF) 1
They were divided into groups and subjected to the test after being shaved.

ラットはネンブタールにより麻酔後圧中線にそって約2
 cm背部皮膚を切開し、ただちに切開部をミノヘル縫
合器により縫合した。縫合後試料0.1m7を1日1回
3週間にわたり切開部に塗布した。3週間後、う、トを
撲殺し跡合剣を外した後断面1cmとなるように皮膚切
片を作成した。張力測定にはテンシロン(Ten5il
on ) UTM−4(東洋測器株式会社製)を用い、
皮膚切片の切断張力を測定した。
Rats were anesthetized with Nembutal and were approximately 2
A centimeter dorsal skin incision was made, and the incision was immediately sutured using a Minohel suture device. After suturing, 0.1 m7 of the sample was applied to the incision site once a day for 3 weeks. Three weeks later, the horse was bludgeoned to death, and a 1 cm skin section was prepared after removing the sword. Tensilon (Ten5il) is used for tension measurement.
on) Using UTM-4 (manufactured by Toyo Sokki Co., Ltd.),
The cutting tension of the skin sections was measured.

結果を表1に示ず0 表1 (以下余白) 表1の結果から02%ヒアルロン酸塗布部位はコントロ
ールに比べ張力が増加し、創傷治癒効果が認められ、同
様に牛牌臓の水抽出物01%塗布においても張力の増加
が観察された。一方、牛牌臓の水抽出物とヒアルロン酸
併用の本発明品の場合は、各々単品塗布の比較品に比べ
て張力の増加が大きく顕著な創傷治癒効果が認められた
。また以上の動物試験だけでなく・人体パネルの場合も
、本発明品は同等の効果を示した。
The results are not shown in Table 1.0 Table 1 (Left below) From the results in Table 1, the tension at the site where 02% hyaluronic acid was applied increased compared to the control, and a wound healing effect was observed. An increase in tension was also observed at 0.01% application. On the other hand, in the case of the product of the present invention in which a water extract of bovine viscera and hyaluronic acid were used in combination, a significant increase in tension was observed compared to a comparative product in which each product was applied alone, and a remarkable wound healing effect was observed. In addition to the above animal tests, the product of the present invention also showed similar effects in human panel tests.

〔試験例2〕 試験例1と同様にしてヒアルロン酸の替わりにエラスチ
ンを用いた場合の創傷治癒効果を評価した。結果を表2
に示す。牛牌臓の水抽出物とエラスチンを配合した本発
明品は各々を単独で配合した比較品と比較して相剰的な
創傷治癒効果を有していることがわかる。
[Test Example 2] In the same manner as Test Example 1, the wound healing effect when elastin was used instead of hyaluronic acid was evaluated. Table 2 shows the results.
Shown below. It can be seen that the product of the present invention containing aqueous extract of bovine viscera and elastin has a complementary wound healing effect compared to a comparative product containing each ingredient alone.

(以下余白) 表2 試 料(重量%) 平均張力(り/cJ)本 牛牌臓の
水抽出物 01 40 発 エラスチン Ol 明 中牌臓の水抽出物 01 46 品 エラスチン 05 比 牛牌臓の水抽出物 0.1 423較 ヒアルロン
酸 0.2 375 品 コントロール −285 (試料は生理食塩水溶液、コントロールは生理食塩水) 次に実施例により本発明をさらに詳細に説明する。本発
明はこれにより限定されるものではない。
(Leaving space below) Table 2 Sample (wt%) Average tension (Li/cJ) Water extract of bovine viscera 01 40 items Elastin Ol Light Water extract of medium viscera 01 46 items Elastin 05 Ratio of beef viscera Water extract 0.1 423 Comparison Hyaluronic acid 0.2 375 Product Control -285 (Sample: physiological saline solution, control: physiological saline) Next, the present invention will be explained in more detail with reference to Examples. The present invention is not limited thereby.

配合量は重量%である。The blending amount is in weight%.

(以下余白) 実施例1 クリーム プロピレングリコール 5.0 セチルアルコール 4.0 ミツロウ 5゜ スクワラン 35.0 う/リン 50 ステアリン酸グリ4求イド z。(Margin below) Example 1 Cream Propylene glycol 5.0 Cetyl alcohol 4.0 Beeswax 5゜ Squalane 35.0 U/Rin 50 Stearic acid glycerol 4 hydride z.

ポリオキシエチレン(20モル) ソルビタンモノラウリン酸エステルz○メチルパラベン
 o1 エチルパラベン 0.15 牛牌臓の水抽出物 0.001 ヒアルロン酸ナトリウム 0.005 香 料 01 イオン交換水 残余 (以下余白) 実施例2 パック ポリビニルアルコール 15.0 ポリエチレングリコール 30 プロピレングリコール 70 エタノール 10.0 メチルパラベン 02 牛牌臓の水抽出物 2−0 コラーゲン 20 香 料 0.1 イオン交換水 残余 (以下余白) 実施例3 化粧水 グリセリン 3゜ プロピレングリコール 4゜ エタノール 8゜ ポリオキシエチレン(20モル)オレイルアルコール 
o5牛牌臓の水抽出物 o1 ヒアルロン酸ナトリウム o1 エラスチン o1 メチル、パラベン o1 クエン酸ソーダ o1 香 料 005 イオン交換水 残余 特許出願人 株式会社 資 生 堂
Polyoxyethylene (20 mol) Sorbitan monolaurate z○ Methylparaben o1 Ethylparaben 0.15 Water extract of bovine viscera 0.001 Sodium hyaluronate 0.005 Fragrance 01 Ion-exchanged water Residual (hereinafter referred to as the margin) Example 2 Packed polyvinyl alcohol 15.0 Polyethylene glycol 30 Propylene glycol 70 Ethanol 10.0 Methylparaben 02 Water extract of bovine viscera 2-0 Collagen 20 Fragrance 0.1 Ion exchange water Remainder (blank below) Example 3 Lotion glycerin 3゜Propylene glycol 4゜Ethanol 8゜Polyoxyethylene (20 mol) Oleyl alcohol
o5 Bovine spleen water extract o1 Sodium hyaluronate o1 Elastin o1 Methyl, paraben o1 Sodium citrate o1 Fragrance 005 Ion exchange water Remaining patent applicant Shiseido Co., Ltd.

Claims (1)

【特許請求の範囲】[Claims] (1〕 ホ乳類の肝臓又は牌臓からの水仙出物と皮膚エ
キスとを含有することを特徴とする化粧料。
(1) A cosmetic characterized by containing a daffodil extract from the liver or spleen of a mammal and a skin extract.
JP58173398A 1983-09-20 1983-09-20 Cosmetic Granted JPS6064909A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58173398A JPS6064909A (en) 1983-09-20 1983-09-20 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58173398A JPS6064909A (en) 1983-09-20 1983-09-20 Cosmetic

Publications (2)

Publication Number Publication Date
JPS6064909A true JPS6064909A (en) 1985-04-13
JPH0412243B2 JPH0412243B2 (en) 1992-03-04

Family

ID=15959669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58173398A Granted JPS6064909A (en) 1983-09-20 1983-09-20 Cosmetic

Country Status (1)

Country Link
JP (1) JPS6064909A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152614A (en) * 1984-12-27 1986-07-11 Sansho Seiyaku Kk Whitening cosmetic
JPS6239510A (en) * 1985-08-13 1987-02-20 Shiseido Co Ltd External preparation for skin
FR2590169A1 (en) * 1985-11-20 1987-05-22 Secta Labo Cosmetologie Y Roch Cosmetic composition containing biostimulins
JPS638313A (en) * 1986-06-27 1988-01-14 Sansho Seiyaku Kk Drug capable of inhibiting melanization for external use
US5032408A (en) * 1985-05-28 1991-07-16 Chemisch Adviesburea Drs. J.C.P. Schruder Composition for treatment of skin affections and process for its preparation
EP1051142A4 (en) * 1997-10-16 2002-01-30 Deguang Zhu A new powerful cosmetic or pharmaceutical composition

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106068455B (en) 2013-07-12 2018-05-11 权宁娥 The method for being used to diagnose the illness using the morphological feature of Luterial

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937816A (en) * 1970-07-21 1976-02-10 Solco Basel Ag Growth regulating compositions extracted from spleen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937816A (en) * 1970-07-21 1976-02-10 Solco Basel Ag Growth regulating compositions extracted from spleen

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152614A (en) * 1984-12-27 1986-07-11 Sansho Seiyaku Kk Whitening cosmetic
US5032408A (en) * 1985-05-28 1991-07-16 Chemisch Adviesburea Drs. J.C.P. Schruder Composition for treatment of skin affections and process for its preparation
JPS6239510A (en) * 1985-08-13 1987-02-20 Shiseido Co Ltd External preparation for skin
FR2590169A1 (en) * 1985-11-20 1987-05-22 Secta Labo Cosmetologie Y Roch Cosmetic composition containing biostimulins
JPS638313A (en) * 1986-06-27 1988-01-14 Sansho Seiyaku Kk Drug capable of inhibiting melanization for external use
EP1051142A4 (en) * 1997-10-16 2002-01-30 Deguang Zhu A new powerful cosmetic or pharmaceutical composition

Also Published As

Publication number Publication date
JPH0412243B2 (en) 1992-03-04

Similar Documents

Publication Publication Date Title
JP3532244B2 (en) Mucopolysaccharide fragmentation inhibitor, active oxygen scavenger and cosmetic
JP3112436B2 (en) In particular, the use of honey as a keratolytic agent to improve the brightness of the skin facial and treat wrinkles
JPH04211004A (en) Cosmetic composition containing an amino acid copolymer useful as a moisturizer
JPH0375523B2 (en)
US4062937A (en) Insect bite relief preparation
DE19617515A1 (en) Conditioning hair treatment agent contg. aminoacid or peptide
JPS6064909A (en) Cosmetic
JPS59196811A (en) Hair setting agent composition
JPS60116618A (en) Cosmetic
JPS5976007A (en) Cosmetic
HU193289B (en) Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
JPS63150210A (en) Hair-tonic cosmetic
US20200222305A1 (en) Natural skin care composition
JP2002145753A (en) Heumectant composition and cosmetic including the same
JPS59219227A (en) Composition for acne treatment
JPH03141213A (en) Hair tonic
JPH06179612A (en) Cosmetic
KR100305186B1 (en) Silicone Emulsion Type Water Soluble Gel Cosmetic Composition With Excellent Sebum Control And Cosmetic Persistence
JP3044690B2 (en) Cosmetics
JPH0429919A (en) Moisture-retaining cosmetic
KR100300197B1 (en) Cosmetics for Power Generation
KR101667308B1 (en) Anti-wrinkle cosmetic composition containing timosaponin, hyaluronic acid, collagen, calendula flower extract
DE19617569A1 (en) Hair treatment prod., e.g. shampoo, styling agent, permanent wave formulation or hair car prod.
JPH09227397A (en) External preparation for skin
JPH06298622A (en) Cosmetic for skin or hair